In this study, we aimed to evaluate whether CX3CR1+ Tregs, which have enhanced trafficking to inflammatory sites through the CX3CL1/CX3CR1 axis, can exert stronger anti-inflammatory and neuroprotective effects in AD. Here, CX3CR1 is linked to Alzheimer disease.